Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
McKinsey
Chinese Patent Office
US Department of Justice
QuintilesIMS
AstraZeneca
Moodys
Express Scripts
Colorcon
Boehringer Ingelheim

Generated: October 22, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: mesalamine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Shire
LIALDA
mesalamine
TABLET, DELAYED RELEASE;ORAL022000NDAKAISER FOUNDATION HOSPITALS0179-0142-7030 TABLET, DELAYED RELEASE in 1 BOX, UNIT-DOSE (0179-0142-70)
Shire
LIALDA
mesalamine
TABLET, DELAYED RELEASE;ORAL022000NDA AUTHORIZED GENERICShire US Manufacturing Inc.54092-100-01120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-100-01)
Shire
LIALDA
mesalamine
TABLET, DELAYED RELEASE;ORAL022000NDAShire US Manufacturing Inc.54092-476-01120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-01)
Shire
LIALDA
mesalamine
TABLET, DELAYED RELEASE;ORAL022000NDAShire US Manufacturing Inc.54092-476-0212 BOTTLE in 1 CARTON (54092-476-02) > 120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-01)
Shire
LIALDA
mesalamine
TABLET, DELAYED RELEASE;ORAL022000NDAShire US Manufacturing Inc.54092-476-083 CARTON in 1 CARTON (54092-476-08) > 8 BLISTER PACK in 1 CARTON > 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK
Shire
LIALDA
mesalamine
TABLET, DELAYED RELEASE;ORAL022000NDAShire US Manufacturing Inc.54092-476-12120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-12)
Shire
LIALDA
mesalamine
TABLET, DELAYED RELEASE;ORAL022000NDAAvera McKennan Hospital69189-0476-11 TABLET, DELAYED RELEASE in 1 DOSE PACK (69189-0476-1)
Valeant Pharms Intl
APRISO
mesalamine
CAPSULE, EXTENDED RELEASE;ORAL022301NDAPhysicians Total Care, Inc.54868-6150-0120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54868-6150-0)
Valeant Pharms Intl
APRISO
mesalamine
CAPSULE, EXTENDED RELEASE;ORAL022301NDASalix Pharmaceuticals, Inc.65649-103-011 BOTTLE in 1 CARTON (65649-103-01) > 4 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Valeant Pharms Intl
APRISO
mesalamine
CAPSULE, EXTENDED RELEASE;ORAL022301NDASalix Pharmaceuticals, Inc.65649-103-021 BOTTLE in 1 CARTON (65649-103-02) > 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Baxter
Citi
US Army
Merck
Teva
Federal Trade Commission
Cantor Fitzgerald
Fish and Richardson
AstraZeneca

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot